Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuter

Showing results (451-460 of 581) with videos related to

Pageof 59
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Cancer Research|April 3, 2008
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancerXuesong Ouyang, Walter J Jessen, Hikmat Al-Ahmadie, et al.
Journal of Pathology Informatics|October 9, 2023
Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational costOrly Ardon, Eric Klein, Allyne Manzo, et al.
The American Journal of Surgical Pathology|August 2, 2007
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrumPedram Argani, Semra Olgac, Satish K Tickoo, et al.
The American Journal of Pathology|July 5, 2001
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescentsP Argani, C R Antonescu, P B Illei, et al.
The Journal of Urology|March 8, 2014
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladderMassimiliano Spaliviero, Guido Dalbagni, Bernard H Bochner, et al.
European Urology|October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and ManagementStanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
The American Journal of Surgical Pathology|January 13, 2005
Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCRPedram Argani, Marick Laé, Brian Hutchinson, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Pageof 59

Showing results (451-460 of 581) with videos related to

Sort By:
Pageof 59
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Cancer Research|April 3, 2008
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancerXuesong Ouyang, Walter J Jessen, Hikmat Al-Ahmadie, et al.
Journal of Pathology Informatics|October 9, 2023
Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational costOrly Ardon, Eric Klein, Allyne Manzo, et al.
The American Journal of Surgical Pathology|August 2, 2007
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrumPedram Argani, Semra Olgac, Satish K Tickoo, et al.
The American Journal of Pathology|July 5, 2001
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescentsP Argani, C R Antonescu, P B Illei, et al.
The Journal of Urology|March 8, 2014
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladderMassimiliano Spaliviero, Guido Dalbagni, Bernard H Bochner, et al.
European Urology|October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and ManagementStanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
The American Journal of Surgical Pathology|January 13, 2005
Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCRPedram Argani, Marick Laé, Brian Hutchinson, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Pageof 59